Showing results (1741-1750 of 5,961) with videos related to
Sort By:
Pageof 597
Endocrine|September 30, 2003
A case of normoreninemic aldosterone-producing adenoma associated with chronic renal failure: case report and literature reviewHiroyuki Koshiyama, Takeshi Fujisawa, Naomitsu Kuwamura, et al.Endocrine|September 30, 2003
Basal endocrine status in African dietary iron overloadLynette McNamara, Vanessa R Panz, Frederick J Raal, et al.Endocrine|September 30, 2003
Relationship between mammaglobin expression and estrogen receptor status in breast tumorsXiao-feng Guan, Mohammad K Hamedani, Adewale Adeyinka, et al.Endocrine|September 30, 2003
Zinc alters the kinetics of IGF-II binding to cell surface receptors and binding proteinsRobert H McCusker, Rebecca L Mateski, Jan NovakofskiEndocrine|December 11, 2003
Tissue-specific regulation by estrogen of ezrin and ezrin/radixin/moesin-binding protein 50Perry M Smith, Ann Cowan, Sharon L Milgram, et al.Endocrine|December 11, 2003
Chronic daily ethanol and withdrawal: 4. Long-term changes in plasma testosterone regulation, but no effect on GnRH gene expression or plasma LH concentrationsDennis D Rasmussen, Dipak K Sarkar, James L Roberts, et al.Endocrine|December 11, 2003
High prevalence of thyroid ultrasonographic abnormalities in primary aldosteronismDecio Armanini, Davide Nacamulli, Carla Scaroni, et al.Endocrine|April 12, 2013
HGF/c-met system targeting PI3K/AKT and STAT3/phosphorylated-STAT3 pathways in pituitary adenomas: an immunohistochemical characterization in view of targeted therapiesMaria Trovato, Maria Luisa Torre, Marta Ragonese, et al.Endocrine|April 16, 2013
Vandetanib: opening a new treatment practice in advanced medullary thyroid carcinomaCosimo Durante, Alessandra Paciaroni, Katia Plasmati, et al.Endocrine|February 16, 2013
Pharmacological characterization of a novel non-AT1, non-AT2 angiotensin binding site identified as neurolysinJamala D Swindle, Kira L Santos, Robert C SpethPageof 597